ClinicalTrials.gg
Sign In

Nevus clinical trials

The registry lists 47 studies for Nevus across more than 10 countries. 9 are recruiting or about to start. 21 of them are mainly about Nevus (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its 2 narrower conditions too, such as Dysplastic Nevus Syndrome: 80 studies, 20 open.

Get an email when these change. Save the Nevus studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
30
Recruiting
5
Status unknown
5
Not yet recruiting
3
Terminated
2
Enrolling by invitation
1

Phase

Phase 1
4
Phase 2
4
Phase 3
1

Where

United States
16
France
5
Germany
3
China
3
Taiwan
2
Russian Federation
2

Who runs them

Memorial Sloan Kettering Cancer Center (3) · Orlucent, Inc (3) · National Cancer Institute (NCI) (3) · Centre Hospitalier Universitaire de Saint Etienne (2) · Ruhr University of Bochum (2) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (2) · Medical University of Graz (2) · University of Auckland, New Zealand (1)

What is being tested here

Drugs under test in Nevus studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Everolimus101
Nivolumab001
CDX-1140001
TGFB3 protein, human001

Coming up

1phase 3 study under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 5 Nevus studies recruiting now, 3 (60%) set no upper age limit and 2 (40%) stop at 75 or younger. 2 (40%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 5
AgeWomenMen
101 (20%)1 (20%)
182 (40%)2 (40%)
302 (40%)2 (40%)
402 (40%)2 (40%)
503 (60%)3 (60%)
653 (60%)3 (60%)
753 (60%)3 (60%)
853 (60%)3 (60%)

Across all 47 studies, recruiting or not: 17% stop at 75 or younger and 17% at 65; 32% take children; 0% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Nevus studies take

Of 14 observational studies under Nevus, half reached primary completion within 34 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational34 mo21–104 · 14 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 47 of 47. search them.